Prospective, Post Marketing Surveillance of CAROGRA Tablets

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT2031220193

Enrollment

300

Registered

2022-07-08

Start date

2022-06-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Moderate ulcerative colitis (limited to those patients who had inadequate response to 5-aminosalicylic acid)

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
Partial Mayo Score	—

Contacts

Public ContactYuki Arai

EA Pharma Co.,Ltd.

contact_ea@eapharma.co.jp+81-3-6280-9814

Outcome results